Company Filing History:
Years Active: 2015
Title: Innovations by Wengong Xi: A Focus on Antihypertensive Pharmaceutical Composition
Introduction: Wengong Xi, a notable inventor based in Tianjin, China, has made significant contributions to the field of pharmaceuticals. With a keen understanding of drug composition and its effects, he has successfully developed a unique formulation aimed at treating hypertension.
Latest Patents: Wengong Xi holds a patent for a pharmaceutical composition comprising candesartan or its esters and chlorthalidone. This innovative composition is designed to improve antihypertensive effects through a specific weight ratio of candesartan or its ester to chlorthalidone, ranging from 5.3:1 to 1:6.25. The formulation is recognized for its synergistic antihypertensive effects, enhancing both the effectiveness and the duration of hypertension management.
Career Highlights: Currently, Wengong Xi works at the Tianjin Institute of Pharmaceutical Research, where he engages in groundbreaking research aimed at advancing pharmaceutical science. His dedication to innovation has positioned him as an important figure within the institution.
Collaborations: In his work, Wengong Xi collaborates with esteemed colleagues such as Lida Tang and Zhuanyou Zhao. Together, they contribute to the advancement of pharmaceutical technologies and enhance the efficacy of treatments available for patients.
Conclusion: Wengong Xi's contributions to pharmaceutical compositions, particularly in the area of antihypertensive medications, underline the importance of innovation in healthcare. His work not only reflects personal achievement but also the collaborative spirit within the Tianjin Institute of Pharmaceutical Research, signaling a bright future for advancements in this critical field.